Back to jobs
New

Senior Manager, Pre-Formulation and Formulation Development

New Haven - CT

Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer.

Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development.

#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X.

Position Summary

The incumbent will combine hands-on pre-formulation expertise with practical oral and parenteral formulation development, moving flexibly between these functions as programs evolve. Responsibilities span compound characterization, animal and toxicology dosing formulations, and first-in-human and Phase 2 drug products, including formulation optimization and technology transfer.

Working with the Drug Product Development team, the role will interpret data, recommend formulations, and deliver creative, phase-appropriate solutions across multiple early-stage programs. Priorities will be agreed with the Head of CMC Technical Operations who leads overall drug product strategy.

This on-site role in New Haven, CT requires regular hands-on laboratory work and reports to the Head of CMC Technical Operations, with a dotted reporting line to the Drug Product Development.

 

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

  • Plan and execute pre-formulation and formulation studies, balancing compound characterization, preclinical dosing needs, and Phase 1/2 formulation development against agreed priorities, material availability, and timelines.
  • Characterize solubility, dissolution, solid-state and particle properties, chemical and physical stability, and excipient compatibility. Interpret analytical and relevant in vivo findings to recommend formulations with Drug Product Development.
  • Develop oral and parenteral animal formulations for pharmacokinetic, efficacy, and non-GLP/GLP toxicology studies. Align vehicle, concentration, dose volume, route, tolerability, and preparation requirements with study teams.
  • Establish dosing-formulation concentration, homogeneity, stability, robustness, and supported hold times with analytical specialists. Transfer reproducible procedures to CROs and resolve formulation issues with Toxicology, DMPK, and QA.
  • Develop early clinical formulations, including spray-dried amorphous solid dispersions and tablets. Screen polymers, solvents, excipients, and processes and assess loading, stability, residual solvents, and dosage-form performance.
  • Develop parenteral prototypes, evaluating pH, osmolality, stability, and dilution and administration compatibility. Apply PEG experience and biologics formulation knowledge, including aggregation and adsorption, with specialist support.
  • Coordinate formulation testing, stability, in-use assessments, and clinical-scale transfer with Drug Product Development, Analytical Development, QA, and qualified manufacturing partners; identify comparison or bridging needs.
  • Manage assigned vendor scopes, technical deliverables, timelines, and approved spend. Prepare development reports, formulation instructions, transfer packages, and relevant CMC content with traceable records and applicable GLP/cGMP compliance.
  • Use focused experiments and documented risk assessments to advance programs efficiently under material, data, and time constraints. Mentor colleagues and maintain laboratory safety, product quality, and compliance.

 

 

Qualifications

  • Strong hands-on pre-formulation and formulation experience, with repeated contributions to IND-enabling and early clinical programs. Ability to move between both functions and solve solubility and stability challenges creatively.
  • Direct experience with oral and parenteral animal formulations, non-GLP/GLP study support, dose-formulation controls, and transfer to CROs or study sites.
  • Spray drying and amorphous solid dispersion experience is required. Tableting and parenteral formulation development experience are required, including practical formulation evaluation and collaboration with manufacturing partners.
  • Experience with PEG-containing drug candidates and working knowledge of biologics formulation, including protein stability, aggregation, adsorption, buffers, and excipients; ability to engage specialists appropriately.
  • Ability to interpret physicochemical and analytical data, including relevant HPLC/UPLC, particle-size, DSC, TGA, and XRPD results. Working knowledge of GLP, early clinical cGMP, data integrity, and technology transfer.
  • Strong experimental design, technical leadership, vendor management, communication, and mentoring skills. Later-stage and commercial experience are desirable, not required. Ability to perform essential on-site laboratory duties with appropriate PPE and reasonable accommodation, where needed.
  • Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
  • The duties of this role are generally conducted in a combination of office and lab environment. Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortable in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours.

 

EDUCATION

  • 5+ years of relevant pharmaceutical or biotechnology experience in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline, including hands-on pre-formulation and early formulation development, technical project leadership, and mentoring.

 

Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com

Arvinas is an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identify, national origin, disability or protected veteran status. 

 

Create a Job Alert

Interested in building your career at Arvinas? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...

Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Arvinas’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...